Journal article
Circulating tumor (ct)-DNA alterations in advanced urothelial carcinoma: Association with outcomes and evolution with therapy.
Abstract
334
Background: Cell-free ctDNA may be potentially actionable, prognostic for outcomes and evolve after therapy. We conducted a retrospective study to evaluate these issues and shed light on UC biology. Methods: Patients (pts) with advanced UC who underwent ctDNA analysis for potentially actionable alterations using Guardant360 were identified. Data were requested for prognostic factors, current and prior therapies, TTF (time …
Authors
Grivas P; Nagy RJ; Pond GR; Gupta S; Wang J; Vaishampayan UN; Pal SK; Bilen MA; Naik G; Ghatalia P
Journal
Journal of Clinical Oncology, Vol. 35, No. 6_suppl, pp. 334–334
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
February 20, 2017
DOI
10.1200/jco.2017.35.6_suppl.334
ISSN
0732-183X